论文部分内容阅读
目的:探究在大肠癌同时性肝转移疾病病人的临床治疗中,其手术治疗方法的临床应用效果。方法:选取2012年8月~2014年10月本院收治的96例大肠癌同时性肝转移病人作为研究对象,将其随机划分为研究组和对比组,每组各48例,对比组病人不予以切除肝转移灶手术治疗,研究组病人采取手术方式切除肝转移灶治疗,对比两组病人治疗效果。结果:研究组病人在采取切除肝转移灶手术治疗后,2年内生存例数为35例,生存率为72.92%,4年内生存例数为26例,生存率为54.17%;对比组病人没有切除肝转移灶,其2年内生存例数为22例,生存率为45.83%,4年内生存例数为15例,生存率为31.25%。研究组病人在生存率方面要明显高于对比组病人,存在显著差异,具有统计学意义(P<0.05)。结论:在大肠癌同时性肝转移疾病病人的临床治疗中,在手术治疗同时,予以切除肝转移灶,具有良好的治疗效果,能极大的提升病人生存率,减少其转移复发等情况,提升病人生活质量。
Objective: To explore the clinical application of surgical treatment in the clinical treatment of patients with concurrent liver metastasis of colorectal cancer. Methods: Ninety-six patients with simultaneous liver metastases from colorectal cancer admitted to our hospital from August 2012 to October 2014 were selected as study subjects and randomly divided into study group and control group, with 48 cases in each group. Patients in the control group Surgical resection of liver metastases was performed. The patients in study group were treated by surgical resection of liver metastases, and the treatment effect was compared between the two groups. Results: In the study group, the number of survivals was 72.92% within 2 years after surgical resection of hepatic metastases. The survival rate was 72.42% within 4 years and the survival rate was 54.17%. The patients in the control group had no resection Liver metastases, the 2-year survival of 22 cases, the survival rate was 45.83%, 4-year survival of 15 cases, the survival rate was 31.25%. The study group patients in the survival rate was significantly higher than the control group of patients, there were significant differences, with statistical significance (P <0.05). Conclusion: In the clinical treatment of patients with concurrent liver metastasis of colorectal cancer, surgical removal of liver metastases was performed at the same time. It has a good therapeutic effect, which can greatly improve the survival rate of patients and reduce their metastasis and recurrence, Quality of patient’s life.